NFKB1 and breast carcinoma: Thus, previous studies have approached the inhibition of NF-κB activity in several ways: Gordon et al. suppressed NF-κB transcription in MDA-MB-231 breast cancer cells resulting in reduced osteolysis after tumor cell injection in mice combined with decreased cytokine expression [53].